BioLife Solutions Inc (BLFS)
BioLife Solutions, Inc. is a healthcare company focused on life sciences tools and services for the cell and gene therapy industry. As a common stock listing on NASDAQ, the company develops, manufactures, and markets bioproduction products and related services used in basic and applied research as well as in commercial manufacturing of biologic-based therapies. Its product portfolio includes biopreservation media such as HypoThermosol FRS and CryoStor Freeze Media, human platelet lysates for cell expansion, CellSeal closed-system vials, CryoCase cryo-compatible containers, automated cell processing equipment, and the ThawSTAR line of automated thawing devices. BioLife Solutions also provides evo shipping containers, which are cloud-connected passive storage and transport systems for temperature-sensitive biologics and pharmaceuticals. The company sells its products directly and through third-party distributors in the United States and in international markets including Europe, the Middle East, and Africa.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-BLFS
|
$22.50
|
-22.4% Downside
|
Overvalued
|
$32.11
|
10.7% Upside
|
Fair
|
Great
|
—
|
—
|
—
|
0.0%
|
August 6, 2026
|
-125.8x
|
3.8x
|
13.9x
|
1.421 B
|
1.314 B
|
1.0%
|
87.4%
|
28.5
|
—
|
-69.5%
|
